Craig-Hallum analyst Albert Lowe initiated coverage of Spruce Biosciences (SPRB) with a Buy rating and $140 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRB:
- Spruce Biosciences Prices Equity Offering to Raise Capital
- Spruce Biosciences 1.15M share Spot Secondary priced at $50.00
- Closing Bell Movers: Amazon gains on expanded Anthropic investment
- Spruce Biosciences down 13% at $60.50 after equity offering announcement
- Spruce Biosciences announces common stock offering, no amount given